Cancer Biotherapy and Radiopharmaceuticals · 2009 · 23 citations · 31 references
PharmacyBiotechnologyOncologyDrug DeliveryGene DeliveryNanoparticle Drug DeliveryAngiogenesisCancer NanomedicineCell-nanoparticle InteractionsNanomaterials For Drug DeliveryNanomedicineNucleic Acid DeliveryCancer NanotherapyCytotoxicity AssaysGene Delivery NanoparticlesIn Vivo DeliveryLymphangiogenesisNanoparticle DeliveryTargeted TransfectionTransfection Reagents
A nonviral gene carrier, calcium carbonate (CaCO(3))-nanoparticle, was evaluated for the efficient in vitro and in vivo delivery of siRNA-targeting vascular endothelial growth factor-C (VEGF-C). The chemically synthesized CaCO(3)-nanoparticle has a 58-nm diameter and a + 28.6-mV positive surface charge. It is capable of forming a CaCO(3)-nanoparticle-DNA complex and transferring DNA into targeted cells with high transfection efficiency, while effectively protecting the encapsulated DNA from degradation. Further, the CaCO(3)-nanoparticle-DNA complex has no obvious cytotoxicity for LoVo cells, while a liposome-DNA complex exhibited measurable cytotoxicity. LoVo cells transfected with a VEGF-C-targeted small interfering RNA (siRNA) via the CaCO(3)-nanoparticle exhibits significantly reduced VEGF-C expression, as measured by real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay, whereas no decrease in VEGF-C expression is observed in cells treated by control transfection. Transfection of LoVo cells with VEGF-C siRNA via the CaCO(3)-nanoparticle also dramatically suppresses tumor lymphangiogenesis, tumor growth, and regional lymph-node metastasis in subcutaneous xenografts. Significant downregulation of VEGF-C messenger RNA expression in a subcutaneous xenograft derived from VEGF-C siRNA-treated LoVo cells was confirmed by real-time PCR, as compared to controls. We conclude that the CaCO(3)-nanoparticle is a novel, nonviral system for the effective delivery of siRNA for cancer gene therapy.
31
Ahmedin Jemal, Thomas S. Murray, Alicia Samuels et al. · CA A Cancer Journal for Clinicians · 2003 · 3.3K citations · Full text
Medicine, Demography, Oncology +17
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
Mihaela Skobe, Thomas Hawighorst, David G. Jackson et al. · Nature Medicine · 2001 · 1.7K citations
Medicine, Cancer Biology, Oncology +16
Christa M. Stoscheck · Methods in enzymology on CD-ROM/Methods in enzymology · 1990 · 1.4K citations